New evidence out of Stanford suggests providers may want to consider ordering follow-up CTs for probably benign nodules earlier than is currently suggested. Doing so reduced mortality rates and prevented more deaths, among other health benefits.
Utilizing five month follow-up for Lung-RADS 3 reduced mortality by 0.08% in men and 0.05% among women. Earlier care also averted deaths (36 male vs. 27 female), yielded more screen-detected cases (13 vs. 7, respectively) and lowered the number of combined low-dose CTs per 1 million people.
Further comparative cost-effectiveness analysis using trial data or simulated population are required to evaluate the impact of alternative diagnostic follow-up on cost-effectiveness analysis.
Read more : https://www.healthimaging.com/topics/oncology/radiologists-lung-rads-early-follow-imaging